Cramer to Trump: 'Get the facts straight' on Merck CEO Ken Frazier and drug pricingPresident Donald Trump should have done his homework on Merck (NYSE: MRK) Chairman and CEO Ken Frazier before spouting off on Twitter and implying Frazier and the drugmaker are behind “ripoff drug prices,” CNBC’s Jim Cramer said on Monday. On Monday morning, Merck tweeted out a statement from Frazier, which read in part: “I am resigning from the President’s American Manufacturing Council.


Read More At Article Source | Article Attribution